-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EdCjmvF8JBsV4MxZHZo5PnCBFTdptT3sRBdmOlKp2Vj/N0RgJY+7/m4xMGVlcGkF o8MFYMIDWuzotRbuybVEyQ== 0000935069-05-002012.txt : 20050729 0000935069-05-002012.hdr.sgml : 20050729 20050728182336 ACCESSION NUMBER: 0000935069-05-002012 CONFORMED SUBMISSION TYPE: N-Q/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050531 FILED AS OF DATE: 20050729 DATE AS OF CHANGE: 20050728 EFFECTIVENESS DATE: 20050729 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPPENHEIMER ENTERPRISE FUND CENTRAL INDEX KEY: 0000939801 IRS NUMBER: 133819189 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: N-Q/A SEC ACT: 1940 Act SEC FILE NUMBER: 811-07265 FILM NUMBER: 05982358 BUSINESS ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 BUSINESS PHONE: 303-768-3200 MAIL ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 FORMER COMPANY: FORMER CONFORMED NAME: OPPENHEIMER NEW ENTERPRISE FUND DATE OF NAME CHANGE: 19950901 FORMER COMPANY: FORMER CONFORMED NAME: OPPENHEIMER SMALL CAP FUND DATE OF NAME CHANGE: 19950228 N-Q/A 1 rq885_15612nq.txt RQ885_15612NQ.TXT ******* PLEASE DISREGARD SUBMISSIONS 0000935069-05-002001, AS THIS FILING WAS FILED WITH INCORRECT CIK NUMBERS ******** UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-07265 Oppenheimer Enterprise Fund --------------------------- (Exact name of registrant as specified in charter) 6803 South Tucson Way, Centennial, Colorado 80112-3924 ------------------------------------------------------ (Address of principal executive offices) (Zip code) Robert G. Zack, Esq. OppenheimerFunds, Inc. Two World Financial Center, New York, New York 10281-1008 - -------------------------------------------------------------------------------- (Name and address of agent for service) Registrant's telephone number, including area code: (303) 768-3200 Date of fiscal year end: AUGUST 31 Date of reporting period: MAY 31, 2005 ITEM 1. SCHEDULE OF INVESTMENTS. Oppenheimer Enterprise Fund STATEMENT OF INVESTMENTS MAY 31, 2005/UNAUDITED - --------------------------------------------------------------------------------
SHARES VALUE - ------------------------------------------------------------------------------------------------------------------------- COMMON STOCKS--99.6% - ------------------------------------------------------------------------------------------------------------------------- CONSUMER DISCRETIONARY--19.3% - ------------------------------------------------------------------------------------------------------------------------- HOTELS, RESTAURANTS & LEISURE--2.4% Cheesecake Factory, Inc. (The) 1 54,000 $ 1,906,740 - ------------------------------------------------------------------------------------------------------------------------- Scientific Games Corp., Cl. A 1 101,000 2,406,830 ----------------- 4,313,570 - ------------------------------------------------------------------------------------------------------------------------- INTERNET & CATALOG RETAIL--1.5% eBay, Inc. 1 71,000 2,698,710 - ------------------------------------------------------------------------------------------------------------------------- LEISURE EQUIPMENT & PRODUCTS--2.9% Brunswick Corp. 78,400 3,374,336 - ------------------------------------------------------------------------------------------------------------------------- Marvel Enterprises, Inc. 1 87,000 1,850,490 ----------------- 5,224,826 - ------------------------------------------------------------------------------------------------------------------------- MEDIA--3.8% Univision Communications, Inc., Cl. A 1 90,000 2,394,900 - ------------------------------------------------------------------------------------------------------------------------- Walt Disney Co. (The) 164,000 4,500,160 ----------------- 6,895,060 - ------------------------------------------------------------------------------------------------------------------------- MULTILINE RETAIL--1.9% Target Corp. 63,200 3,393,840 - ------------------------------------------------------------------------------------------------------------------------- SPECIALTY RETAIL--4.3% Best Buy Co., Inc. 35,000 1,905,050 - ------------------------------------------------------------------------------------------------------------------------- Chico's FAS, Inc. 1 68,400 2,339,964 - ------------------------------------------------------------------------------------------------------------------------- Urban Outfitters, Inc. 1 65,900 3,515,106 ----------------- 7,760,120 - ------------------------------------------------------------------------------------------------------------------------- TEXTILES, APPAREL & LUXURY GOODS--2.5% Coach, Inc. 1 110,400 3,206,016 - ------------------------------------------------------------------------------------------------------------------------- Polo Ralph Lauren Corp. 36,800 1,426,000 ----------------- 4,632,016 - ------------------------------------------------------------------------------------------------------------------------- CONSUMER STAPLES--2.2% - ------------------------------------------------------------------------------------------------------------------------- BEVERAGES--2.2% PepsiCo, Inc. 71,000 3,994,460 - ------------------------------------------------------------------------------------------------------------------------- ENERGY--4.8% - ------------------------------------------------------------------------------------------------------------------------- ENERGY EQUIPMENT & SERVICES--1.5% Smith International, Inc. 47,000 2,761,720 - ------------------------------------------------------------------------------------------------------------------------- OIL & GAS--3.3% Amerada Hess Corp. 37,000 3,435,450 - ------------------------------------------------------------------------------------------------------------------------- Apache Corp. 43,000 2,526,680 ----------------- 5,962,130 - ------------------------------------------------------------------------------------------------------------------------- FINANCIALS--8.2% - ------------------------------------------------------------------------------------------------------------------------- CONSUMER FINANCE--0.8% First Marblehead Corp. (The) 1 33,500 1,495,775 - ------------------------------------------------------------------------------------------------------------------------- DIVERSIFIED FINANCIAL SERVICES--5.2% American Express Co. 113,500 6,111,975 - ------------------------------------------------------------------------------------------------------------------------- Goldman Sachs Group, Inc. (The) 34,000 3,315,000 ----------------- 9,426,975 - ------------------------------------------------------------------------------------------------------------------------- INSURANCE--2.2% AMBAC Financial Group, Inc. 53,700 3,874,455
1 | OPPENHEIMER ENTERPRISE FUND Oppenheimer Enterprise Fund STATEMENT OF INVESTMENTS MAY 31, 2005/UNAUDITED - --------------------------------------------------------------------------------
SHARES VALUE - ------------------------------------------------------------------------------------------------------------------------- COMMON STOCKS CONTINUED - ------------------------------------------------------------------------------------------------------------------------- HEALTH CARE--17.5% - ------------------------------------------------------------------------------------------------------------------------- BIOTECHNOLOGY--7.0% Amgen, Inc. 1 50,600 $ 3,166,548 - ------------------------------------------------------------------------------------------------------------------------- Celgene Corp. 1 33,000 1,397,220 - ------------------------------------------------------------------------------------------------------------------------- Genentech, Inc. 1 34,500 2,734,125 - ------------------------------------------------------------------------------------------------------------------------- Genzyme Corp. (General Division) 1 18,400 1,147,976 - ------------------------------------------------------------------------------------------------------------------------- Gilead Sciences, Inc. 1 73,000 2,978,400 - ------------------------------------------------------------------------------------------------------------------------- Martek Biosciences Corp. 1 34,900 1,304,911 ----------------- 12,729,180 - ------------------------------------------------------------------------------------------------------------------------- HEALTH CARE EQUIPMENT & SUPPLIES--4.2% Gen-Probe, Inc. 1 39,200 1,523,312 - ------------------------------------------------------------------------------------------------------------------------- Immucor, Inc. 1 70,000 2,345,000 - ------------------------------------------------------------------------------------------------------------------------- Varian Medical Systems, Inc. 1 98,400 3,700,824 ----------------- 7,569,136 - ------------------------------------------------------------------------------------------------------------------------- HEALTH CARE PROVIDERS & SERVICES--3.8% Coventry Health Care, Inc. 1 43,000 2,993,660 - ------------------------------------------------------------------------------------------------------------------------- Lincare Holdings, Inc. 1 40,000 1,758,400 - ------------------------------------------------------------------------------------------------------------------------- WellCare Health Plans, Inc. 1 58,000 2,012,600 ----------------- 6,764,660 - ------------------------------------------------------------------------------------------------------------------------- PHARMACEUTICALS--2.5% Allergan, Inc. 21,600 1,669,896 - ------------------------------------------------------------------------------------------------------------------------- Pfizer, Inc. 103,300 2,882,070 ----------------- 4,551,966 - ------------------------------------------------------------------------------------------------------------------------- INDUSTRIALS--9.2% - ------------------------------------------------------------------------------------------------------------------------- AEROSPACE & DEFENSE--2.1% Rockwell Collins, Inc. 77,000 3,803,030 - ------------------------------------------------------------------------------------------------------------------------- COMMERCIAL SERVICES & SUPPLIES--2.0% Corporate Executive Board Co. 24,500 1,709,610 - ------------------------------------------------------------------------------------------------------------------------- Stericycle, Inc. 1 38,000 1,885,560 ----------------- 3,595,170 - ------------------------------------------------------------------------------------------------------------------------- INDUSTRIAL CONGLOMERATES--2.9% General Electric Co. 145,000 5,289,600 - ------------------------------------------------------------------------------------------------------------------------- MACHINERY--1.2% Donaldson Co., Inc. 68,200 2,189,220 - ------------------------------------------------------------------------------------------------------------------------- TRADING COMPANIES & DISTRIBUTORS--1.0% Fastenal Co. 31,000 1,801,720 - ------------------------------------------------------------------------------------------------------------------------- INFORMATION TECHNOLOGY--37.5% - ------------------------------------------------------------------------------------------------------------------------- COMMUNICATIONS EQUIPMENT--8.2% Avaya, Inc. 1 267,000 2,443,050 - ------------------------------------------------------------------------------------------------------------------------- Cisco Systems, Inc. 1 175,500 3,401,190 - ------------------------------------------------------------------------------------------------------------------------- Comverse Technology, Inc. 1 147,400 3,468,322 - ------------------------------------------------------------------------------------------------------------------------- QUALCOMM, Inc. 148,000 5,514,480 ----------------- 14,827,042 - ------------------------------------------------------------------------------------------------------------------------- COMPUTERS & PERIPHERALS--4.8% Dell, Inc. 1 91,000 3,629,990 - -------------------------------------------------------------------------------------------------------------------------
2 | OPPENHEIMER ENTERPRISE FUND Oppenheimer Enterprise Fund STATEMENT OF INVESTMENTS MAY 31, 2005/UNAUDITED - --------------------------------------------------------------------------------
SHARES VALUE - ------------------------------------------------------------------------------------------------------------------------- COMMON STOCKS CONTINUED - ------------------------------------------------------------------------------------------------------------------------- COMPUTERS & PERIPHERALS CONTINUED EMC Corp. 1 362,000 $ 5,089,720 ----------------- 8,719,710 - ------------------------------------------------------------------------------------------------------------------------- INTERNET SOFTWARE & SERVICES--5.0% Google, Inc., Cl. A 1 10,000 2,784,000 - ------------------------------------------------------------------------------------------------------------------------- VeriSign, Inc. 1 49,000 1,585,150 - ------------------------------------------------------------------------------------------------------------------------- Yahoo!, Inc. 1 125,000 4,650,000 ----------------- 9,019,150 - ------------------------------------------------------------------------------------------------------------------------- IT SERVICES--1.6% Cognizant Technology Solutions Corp. 1 61,000 2,928,000 - ------------------------------------------------------------------------------------------------------------------------- SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT--7.9% Broadcom Corp., Cl. A 1 116,000 4,116,840 - ------------------------------------------------------------------------------------------------------------------------- Fairchild Semiconductor International, Inc., Cl. A 1 121,000 1,730,300 - ------------------------------------------------------------------------------------------------------------------------- Microsemi Corp. 1 110,000 2,269,300 - ------------------------------------------------------------------------------------------------------------------------- Texas Instruments, Inc. 223,600 6,180,304 ----------------- 14,296,744 - ------------------------------------------------------------------------------------------------------------------------- SOFTWARE--10.0% Amdocs Ltd. 1 108,000 2,943,000 - ------------------------------------------------------------------------------------------------------------------------- Autodesk, Inc. 122,000 4,828,760 - ------------------------------------------------------------------------------------------------------------------------- Microsoft Corp. 326,000 8,410,800 - ------------------------------------------------------------------------------------------------------------------------- SAP AG, Sponsored ADR 48,200 1,988,250 ----------------- 18,170,810 - ------------------------------------------------------------------------------------------------------------------------- TELECOMMUNICATION SERVICES--0.9% - ------------------------------------------------------------------------------------------------------------------------- WIRELESS TELECOMMUNICATION SERVICES--0.9% SpectraSite, Inc. 1 26,800 1,711,180 ----------------- Total Common Stocks (Cost $152,838,463) 180,399,975 - ------------------------------------------------------------------------------------------------------------------------- PREFERRED STOCKS--0.0% - ------------------------------------------------------------------------------------------------------------------------- Multiplex, Inc., Cv., Series C 1,2,3 (Cost $3,999,998) 543,478 25,815 PRINCIPAL AMOUNT - ------------------------------------------------------------------------------------------------------------------------- JOINT REPURCHASE AGREEMENTS--0.6% - ------------------------------------------------------------------------------------------------------------------------- Undivided interest of 0.09% in joint repurchase agreement (Principal Amount/Value $1,220,266,000, with a maturity value of $1,220,367,689) with UBS Warburg LLC, 3%, dated 5/31/05, to be repurchased at $1,130,094 on 6/1/05, collateralized by Federal National Mortgage Assn., 4.50%--6%, 3/1/20--4/1/35, with a value of $1,246,387,946 (Cost $1,130,000) $ 1,130,000 1,130,000 - ------------------------------------------------------------------------------------------------------------------------- TOTAL INVESTMENTS, AT VALUE (COST $157,968,461) 100.2% 181,555,790 - ------------------------------------------------------------------------------------------------------------------------- LIABILITIES IN EXCESS OF OTHER ASSETS (0.2) (324,594) ----------------------------------- NET ASSETS 100.0% $ 181,231,196 ===================================
FOOTNOTES TO STATEMENT OF INVESTMENTS 1. Non-income producing security. 3 | OPPENHEIMER ENTERPRISE FUND Oppenheimer Enterprise Fund STATEMENT OF INVESTMENTS MAY 31, 2005/UNAUDITED - -------------------------------------------------------------------------------- 2. Illiquid or restricted security. The aggregate value of illiquid or restricted securities as of May 31, 2005 was $25,815, which represents 0.01% of the Fund's net assets, all of which is considered restricted. See accompanying Notes to Quarterly Statement of Investments. 3. Affiliated company. Represents ownership of at least 5% of the voting securities of the issuer, and is or was an affiliate, as defined in the Investment Company Act of 1940, at or during the period ended May 31, 2005. The aggregate fair value of securities of affiliated companies held by the Fund as of May 31, 2005 amounts to $25,815. Transactions during the period in which the issuer was an affiliate are as follows:
SHARES GROSS GROSS SHARES AUGUST 31, 2004 ADDITIONS REDUCTIONS MAY 31, 2005 - ---------------------------------------------------------------------------------------------------------- Axsun Technologies, Inc., Cv., Series C 514,139 -- 514,139 -- Multiplex, Inc., Cv., Series C 543,478 -- -- 543,478
DIVIDEND REALIZED VALUE INCOME LOSS - ---------------------------------------------------------------------------------------------------------- Axsun Technologies, Inc., Cv., Series C $ -- $ -- $ 5,691,519 Multiplex, Inc., Cv., Series C 25,815 -- --
FEDERAL TAX. The approximate aggregate cost of securities and other investments and the composition of unrealized appreciation and depreciation of securities and other investments for federal income tax purposes as of May 31, 2005 are noted below. The primary difference between book and tax appreciation or depreciation of securities and other investments, if applicable, is attributable to the tax deferral of losses. Federal tax cost of securities $158,061,871 ============= Gross unrealized appreciation $ 32,857,549 Gross unrealized depreciation (9,363,630) ------------- Net unrealized appreciation $ 23,493,919 ============= NOTES TO QUARTERLY STATEMENT OF INVESTMENTS SECURITIES VALUATION. The Fund calculates the net asset value of its shares as of the close of The New York Stock Exchange (the Exchange), normally 4:00 P.M. Eastern time, on each day the Exchange is open for business. Securities listed or traded on National Stock Exchanges or other domestic or foreign exchanges are valued based on the last sale price of the security traded on that exchange prior to the time when the Fund's assets are valued. Securities traded on NASDAQ are valued based on the closing price provided by NASDAQ prior to the time when the Fund's assets are valued. In the absence of a sale, the security is valued at the last sale price on the prior trading day, if it is within the spread of the closing "bid" and "asked" prices, and if not, at the closing bid price. Corporate, government and municipal debt instruments having a remaining maturity in excess of sixty days and all mortgage-backed securities will be valued at the mean between the "bid" and "asked" prices. Futures contracts traded on a commodities or futures exchange will be valued at the final settlement price or official closing price on the principal exchange as reported by such principal exchange at its trading session ending at, or most recently prior to, the time when the Fund's assets are valued. Securities may be valued primarily using dealer-supplied valuations or a portfolio pricing service authorized by the Board of Trustees. Securities (including restricted securities) for which market quotations are not readily available are valued at their fair value. Foreign and domestic securities whose values have been materially affected by what the Manager identifies as a significant event occurring before the Fund's assets are valued but after the close of their respective exchanges will be fair valued. Fair value is determined in good faith using consistently applied procedures under the supervision of the Board of Trustees. Short-term "money market type" debt securities with remaining maturities of sixty days or less are valued at amortized cost (which approximates market value). 4 | OPPENHEIMER ENTERPRISE FUND Oppenheimer Enterprise Fund STATEMENT OF INVESTMENTS MAY 31, 2005/UNAUDITED - -------------------------------------------------------------------------------- JOINT REPURCHASE AGREEMENTS. Pursuant to an Exemptive Order issued by the Securities and Exchange Commission, the Fund, along with other affiliated funds advised by the Manager, may transfer uninvested cash balances into joint trading accounts on a daily basis. These balances are invested in one or more repurchase agreements. Securities pledged as collateral for repurchase agreements are held by a custodian bank until the agreements mature. Each agreement requires that the market value of the collateral be sufficient to cover payments of interest and principal. In the event of default by the other party to the agreement, retention of the collateral may be subject to legal proceedings. ILLIQUID OR RESTRICTED SECURITIES. As of May 31, 2005, investments in securities included issues that are illiquid or restricted. Restricted securities are purchased in private placement transactions, are not registered under the Securities Act of 1933, may have contractual restrictions on resale, and are valued under methods approved by the Board of Trustees as reflecting fair value. A security may also be considered illiquid if it lacks a readily available market or if its valuation has not changed for a certain period of time. The Fund will not Invest more than 10% of its net assets (determined at the time of purchase and reviewed periodically) in illiquid or restricted securities. Certain restricted securities, eligible for resale to qualified institutional investors, are not subject to that limitation. Securities that are illiquid or restricted are marked with the applicable footnote on the Statement of Investments. Information concerning restricted securities is as follows:
ACQUISITION VALUATION AS OF UNREALIZED SECURITY DATE COST MAY 31, 2005 DEPRECIATION - ------------------------------------------------------------------------------------------------------ Multiplex, Inc., Cv., Series C 2/9/01 $ 3,999,998 $ 25,815 $ 3,974,183
5 | OPPENHEIMER ENTERPRISE FUND ITEM 2. CONTROLS AND PROCEDURES. (a) Based on their evaluation of registrant's disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940 (17 CFR 270.30a-3(c)) as of May 31, 2005, registrant's principal executive officer and principal financial officer found registrant's disclosure controls and procedures to provide reasonable assurances that information required to be disclosed by registrant in the reports that it files under the Securities Exchange Act of 1934 (a) is accumulated and communicated to registrant's management, including its principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure, and (b) is recorded, processed, summarized and reported, within the time periods specified in the rules and forms adopted by the U.S. Securities and Exchange Commission. (b) There have been no significant changes in registrant's internal controls over financial reporting that occurred during the registrant's last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting. ITEM 3. EXHIBITS. (a) Exhibits attached hereto. (Attach certifications as exhibits) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Oppenheimer Enterprise Fund By: /s/ John V. Murphy ------------------- John V. Murphy Principal Executive Officer Date: July 15, 2005 Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. By: /s/ John V. Murphy ------------------- John V. Murphy Principal Executive Officer Date: July 15, 2005 By: /s/ Brian W. Wixted -------------------- Brian W. Wixted Date: July 15, 2005 EX-99.CERT 2 rq885_15612ex302.txt RQ885_15612EX302.TXT Exhibit 99.CERT Section 302 Certifications CERTIFICATIONS I, JOHN V. MURPHY, certify that: 1. I have reviewed this report on Form N-Q of Oppenheimer Enterprise Fund; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed; 4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and (d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of trustees (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. /s/ John V. Murphy - ------------------- John V. Murphy Principal Executive Officer Date: July 15, 2005 Exhibit 99.CERT Section 302 Certifications CERTIFICATIONS I, BRIAN W. WIXTED, certify that: 6. I have reviewed this report on Form N-Q of Oppenheimer Enterprise Fund; 7. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 8. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed; 9. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and (d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 10. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of trustees (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. /s/ Brian W. Wixted - -------------------- Brian W. Wixted Chief Financial Officer Date: July 15, 2005 -----END PRIVACY-ENHANCED MESSAGE-----